Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
56.25
+2.51 (4.67%)
At close: Sep 26, 2025, 4:00 PM EDT
57.00
+0.75 (1.33%)
After-hours: Sep 26, 2025, 6:22 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $4.02 billion as of September 26, 2025. Its market cap has increased by 40.90% in one year.
Market Cap
4.02B
Enterprise Value
3.14B
1-Year Change
40.90%
Ranking
Category
Stock Price
$56.25
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $4.02B, an increase of 381.94%. That is a compound annual growth rate of 36.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 4.02B | 54.36% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |